Moderna Inc.’s latest steps to shore up its financial future include a new loan from a global alternative investment manager.

The Cambridge drugmaker has signed a five-year term loan for up to $1.5 billion of capital from Ares Management Credit Funds.

Stream NBC10 Boston news for free, 24/7, wherever you are. WATCH HERE

More on this story from Boston Business Journal

See Full Page